Cancer drug may be able to treat inflammation caused by COVID-19 virus: Singapore-US study Toggle share menu
Advertisement
Cancer drug may be able to treat inflammation caused by COVID-19 virus: Singapore-US study
Dr Anand Jeyasekharan with a vial of Topotecan, a cancer drug that could potentially be used in the treatment of COVID-19. (Photo: National University Cancer Institute, Singapore)
07 Apr 2021 09:50PM) Share this content
Bookmark
SINGAPORE: A widely available and inexpensive drug used for cancer treatment could potentially be used in the treatment of COVID-19, according to a study by Singapore and US researchers.
They found that the chemotherapeutic drug, called Topotecan, reduced the severity and death rates of infection by the virus that causes COVID-19, by suppressing inflammation in the lungs of laboratory animals.
Even after late start, anti-inflammatory drug protects against lethal inflammation from COVID
scienceblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scienceblog.com Daily Mail and Mail on Sunday newspapers.
Drug protects against COVID-19 inflammation in pre-clinical trials
drugtargetreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from drugtargetreview.com Daily Mail and Mail on Sunday newspapers.